We are live on ! Find out more
GCM

Greywolf Capital Management Portfolio holdings

AUM $67.3M
1-Year Est. Return 100.05%
This Fund
S&P 500
This Quarter Est. Return
-13.61%
1 Year Est. Return
+100.05%
3 Year Est. Return
+174.41%
5 Year Est. Return
+148.91%
10 Year Est. Return
AUM
$460M
AUM Growth
-$119M
Cap. Flow
-$96.6M
Cap. Flow %
-20.98%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
5
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 15.73%
2 Financials 5.87%
3 Communication Services 5.46%
4 Healthcare 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$320M 69.49%
1,527,500
-150,000
-9% -$31.1M
NPO icon
2
Enpro
NPO
$6.42B
$60.1M 13.05%
1,353,329
-194,219
-13% -$10.1M
COOP
3
DELISTED
Mr. Cooper
COOP
$27M 5.87%
1,015,153
-179,783
-15% -$4.93M
HMHC
4
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$21.2M 4.6%
1,354,300
-1,594,200
-54% -$29M
AMAG
5
DELISTED
AMAG Pharmaceuticals
AMAG
$15.8M 3.44%
+662,330
New +$15.2M
LXFR icon
6
Luxfer Holdings
LXFR
$459M
$12.4M 2.68%
1,027,548
-28,904
-3% -$357K
CMLS
7
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$3.98M 0.86%
1,605,672
+339,863
+27% +$980K
CSWC icon
8
Capital Southwest
CSWC
$1.61B
-163,013
Closed -$2.26M
TARO
9
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
-244,686
Closed -$35.1M

Similar funds

Greywolf Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Greywolf Capital Management held 9 positions worth $460M, down 21% from $580M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greywolf Capital Management withdrew a net $96.6M in Q2 2016, closing 2 positions and reducing 5 holdings. Its most notable exit was Taro Pharmaceutical Industries Ltd., an estimated $35.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Greywolf Capital Management opened a new position in AMAG Pharmaceuticals worth $15.8M.

  • Greywolf Capital Management's largest Q2 2016 buy was AMAG Pharmaceuticals: 662,330 shares worth $15.8M.
  • Greywolf Capital Management added most to Cumulus Media Inc. Class A Common Stock in Q2 2016, an estimated $980K increase.
  • Greywolf Capital Management's biggest Q2 2016 reduction was Houghton Mifflin Harcourt Company, cutting an estimated $29M.
  • Greywolf Capital Management fully exited Taro Pharmaceutical Industries Ltd. in Q2 2016, selling an estimated $35.1M.
  • Greywolf Capital Management's ten largest holdings make up 100% of its $460M portfolio in Q2 2016.
  • Greywolf Capital Management opened 1 new position and closed 2 in Q2 2016.
  • Greywolf Capital Management's portfolio value fell 21% quarter-over-quarter to $460M.

Based on Greywolf Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.